Little to lose and no other options: Ethical issues in efforts to facilitate expanded access to investigational drugs

Eline M. Bunnik, Nikkie Aarts and Suzanne van de Vathorst

Health Policy, 2018, vol. 122, issue 9, 977-983

Abstract: Today, public and private bodies around the world are trying to facilitate and increase expanded access to unapproved, investigational drugs for patients with unmet medical needs.

Keywords: Bioethical issues; Investigational drugs; Drug approval; Compassionate use; Ethics (search for similar items in EconPapers)
Date: 2018
References: View references in EconPapers View complete reference list from CitEc
Citations: View citations in EconPapers (1)

Downloads: (external link)
http://www.sciencedirect.com/science/article/pii/S0168851018301842
Full text for ScienceDirect subscribers only

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:eee:hepoli:v:122:y:2018:i:9:p:977-983

DOI: 10.1016/j.healthpol.2018.06.005

Access Statistics for this article

Health Policy is currently edited by Katrien Kesteloot, Mia Defever and Irina Cleemput

More articles in Health Policy from Elsevier
Bibliographic data for series maintained by Catherine Liu () and ().